Vedere Bio

Business model

Gene therapy research for inherited and age-related vision loss conditions.

In brief

Backed by blue-chip biotech investors, it worked on gene therapies aiming to restore vision in patients with inherited retinal diseases, building on encouraging early results in mouse trials. Subsequent preclinical data failed to demonstrate the efficacy needed to justify advanci…

See the What Happened tab for the full account.